Dementia is a growing concern in the UK, affecting approximately 944,000 individuals currently. This number is projected to rise to over 1 million by 2030 and 1.4 million by 2040. As the leading cause of death in the UK, accounting for over 74,000 deaths in 2022, the impact of dementia on individuals, families, and the healthcare system is profound. Early detection through preventative assessments offers a proactive approach, enabling timely interventions that can significantly enhance quality of life.
Understanding Dementia and Its Impact
Dementia encompasses a range of neurological conditions characterised by a decline in cognitive function, affecting memory, thinking, and social abilities. Alzheimer’s disease is the most common form, but other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. The prevalence of dementia increases with age, with 1 in 11 people over 65 affected in the UK.
As well as the personal toll, dementia imposes significant economic and societal burdens. The cost of dementia care in the UK is substantial, and with an ageing population, these challenges are set to increase. However, research suggests that up to 40% of dementia cases may be preventable through addressing 12 key risk factors, highlighting the importance of early intervention.
Advancements in Dementia Detection
In recent years, there has been remarkable progress in dementia detection technologies, enhancing the accuracy and accessibility of early diagnosis. Key developments include:
- Blood-Based Biomarkers: Researchers are exploring blood tests to identify biomarkers associated with dementia, such as specific proteins linked to Alzheimer’s disease. These tests promise a less invasive and more cost-effective alternative to current diagnostic methods and could be available on the NHS by 2030.
- Neuroimaging Techniques: Advanced imaging technologies, like positron emission tomography (PET) scans, have been developed to study amyloid and tau proteins in the brains of individuals with Alzheimer’s disease. These specialized scans aim to enhance understanding of the disease process and identify individuals who may benefit from new drug treatments.
- Machine Learning Algorithms: Artificial intelligence is being harnessed to analyse complex datasets, identifying subtle patterns indicative of early-stage dementia. For instance, a multi-modal machine learning approach has been proposed to automate the recognition of early dementia stages among British Sign Language users, combining features from various body movements and facial expressions.
- Smart Monitoring Systems: Innovative use of smart meters and home sensors allows for the detection of changes in daily routines and behaviours, serving as early indicators of cognitive decline. A study demonstrated that analysing home energy usage patterns could help monitor the well-being of individuals with dementia, facilitating timely interventions.
The Importance of Preventative Assessments
Early detection of dementia through preventative assessments offers several benefits:
- Timely Interventions: Identifying dementia at an early stage allows for the implementation of strategies to manage symptoms, potentially slowing disease progression and improving quality of life.
- Access to Support Services: An early diagnosis enables individuals and their families to access support networks, educational resources, and planning services, facilitating better coping mechanisms.
- Eligibility for Clinical Trials: Early-stage patients may have opportunities to participate in clinical trials for new treatments, contributing to advancements in dementia care.
- Financial and Legal Planning: Early diagnosis provides time to make informed decisions regarding financial affairs, legal matters, and long-term care preferences.
Taking Action: How to Get Assessed
If you have concerns about cognitive health for yourself or a loved one, consider the following steps:
- Consult Your GP: Discuss any memory or cognitive concerns with your general practitioner, who can perform initial assessments and refer you to a specialist if necessary.
- Specialist Clinics: Memory clinics and neurology departments offer comprehensive evaluations, including cognitive testing and imaging studies.
As more people getting diagnosed with dementia, embracing preventative health measures is more crucial than ever. Advancements in detection technologies are enhancing our ability to diagnose dementia early, paving the way for timely interventions that can significantly impact disease progression and quality of life. By prioritising early assessment and proactive management, we can shift from reactive treatment to preventative care.
What Happens During a Dementia Assessment?
Echelon Health have developed the gold standard in detecting your risk of developing dementia.
Our Dementia Assessment offers clarity and accuracy in detecting the earliest signs of the disease, looking underneath the surface to unearth underlying causes of cognitive decline, for effective management and potential treatment.
The Dementia Assessment includes the following:
1. Clients would undergo in-depth blood tests for those risk factors which have been implicated in the development of cognitive impairment. These include haematology, renal and liver function, tests for diabetes, cholesterol and its sub-types, thyroid gland function, levels of vitamin D, B12 and folic acid as well as markers of inflammation.
2. Clients will undergo an advanced 3T MRI brain scan to provide incredibly detailed views of the brain. This scan will be reported by the lead neuroradiologist at Queens Square (National Hospital for Neurology).
3. The client will undergo an in-depth cognitive and formal neuropsychological assessment by a consultant specialist in cognitive decline.
The memory assessment involves a detailed history and a neurocognitive test called the Addenbrookes cognitive assessment (ACE-III). This is a sensitive test used to assess memory disorders and a gold standard for established memory clinics. The assessment can be delivered online but facilities are available for a face to face session, particularly where a neurological examination is felt to be helpful. The ACE-III is sensitive to the early stages of dementia and is composed of tests of attention, memory, language, visual and spatial skills of the brain’. This test has a sensitivity score of up to 97%.
The mental functions tested include:
· General intellect.
· Reading/reading comprehension.
· Language usage and understanding of what others say.
· Attention/concentration.
· Processing speed.
· Learning and memory.
· Reasoning.
· Executive functions, which are higher-level skills you use to organise and plan, manage your time, problem-solve, multi-task, make judgments and maintain self-control.
· Visuospatial skills.
· Motor speed and dexterity.
· Mood and personality.
4. Nuclear Medicine CT-PET Scan:
If our specialist observes any concerning signs, a nuclear medicine CT-PET scan targeting amyloid may be recommended. This advanced imaging test can identify amyloid deposits in the brain, a key characteristic of Alzheimer’s disease, providing additional diagnostic information.
5. Bespoke Support:
Following the assessment, clients receive personalised counselling on the most recent treatments for dementia, including newly approved drugs that target amyloid proteins.
For a confidential conversation with our Head of Private Clients, contact our team today. We will always be delighted to help give you more information and answer any questions you may have.
Listen to the Wealth of Health podcast episode on Dementia, on YouTube or Spotify now.
Did you enjoy this blog? If so, we think you’d enjoy the Wealth of Health podcast. Find us on YouTube and Spotify
Sources
· https://www.alzheimers.org.uk/blog/blood-biomarker-challenge-dementia-diagnosis
· https://dementiastatistics.org/
· https://www.nhs.uk/conditions/dementia/
· https://research.uhs.nhs.uk/news/pioneering-laser-test-could-diagnose-dementia-early-in-the-disease
